Novavax Inc. buy mixitrader
Start price
22.11.25
/
50%
€5.61
Target price
22.11.26
€56.00
Performance (%)
6.28%
Price
20:30
€5.96
Summary
This prediction is currently active. The BUY prediction by mixitrader shows slight gains of 6.28%. This prediction currently runs until 22.11.26. The prediction end date can be changed by mixitrader at any time. mixitrader has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novavax Inc. | 6.28% |
| iShares Core DAX® | 1.614% |
| iShares Nasdaq 100 | 2.191% |
| iShares Nikkei 225® | -0.459% |
| iShares S&P 500 | 2.385% |
According to mixitrader what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Very positive Cash Flow expected
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Very capable Management
Very good company culture
Strong uniques
Very differentiated customer and product portfolio
Undervalued
EBIT growth > 30% per year expected
High Investments for future growth
Very valuable balance sheet
Leading role in innovation
Growths much faster than the competition
Sustainability is very important
Management is a major shareholder
Small Risks for its business
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
Comments by mixitrader for this prediction
In the thread Novavax Inc. diskutieren
Buy mit Kursziel 56,0
Stopped prediction by mixitrader for Novavax Inc.
Novavax Inc.
Start price
Target price
Perf. (%)
€8.09
05.10.25
05.10.25
€80.00
05.10.26
05.10.26
-12.17%
11.10.25
11.10.25
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.15
19.01.25
19.01.25
€81.00
19.01.26
19.01.26
1.84%
01.02.25
01.02.25
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.64
04.01.25
04.01.25
€85.00
04.01.26
04.01.26
-5.65%
18.01.25
18.01.25
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.43
22.12.24
22.12.24
€83.00
22.12.25
22.12.25
2.38%
04.01.25
04.01.25
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.52
07.12.24
07.12.24
€84.00
07.12.25
07.12.25
-1.00%
21.12.24
21.12.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.16
23.11.24
23.11.24
€81.00
23.11.25
23.11.25
4.44%
07.12.24
07.12.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.27
09.11.24
09.11.24
€83.00
09.11.25
09.11.25
-1.31%
23.11.24
23.11.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.99
26.10.24
26.10.24
€90.00
26.10.25
26.10.25
-8.04%
09.11.24
09.11.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€11.57
12.10.24
12.10.24
€114.00
12.10.25
12.10.25
-22.29%
26.10.24
26.10.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€11.45
31.08.24
31.08.24
€112.00
31.08.25
31.08.25
7.13%
14.09.24
14.09.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€14.19
25.05.24
25.05.24
€142.00
25.05.25
25.05.25
19.87%
08.06.24
08.06.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€8.70
11.05.24
11.05.24
€82.00
11.05.25
11.05.25
39.26%
19.05.24
19.05.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€4.89
16.03.24
16.03.24
€48.00
16.03.25
16.03.25
-12.06%
30.03.24
30.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€4.85
02.03.24
02.03.24
€49.00
02.03.25
02.03.25
0.78%
16.03.24
16.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€5.15
27.02.24
27.02.24
€51.00
27.02.25
27.02.25
-5.71%
02.03.24
02.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€7.61
02.09.23
02.09.23
€76.00
02.09.24
02.09.24
-4.94%
16.09.23
16.09.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€7.06
30.04.23
30.04.23
€120.00
30.04.24
30.04.24
9.75%
13.05.23
13.05.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€165.88
07.08.21
07.08.21
€50.00
07.08.22
07.08.22
20.57%
21.08.21
21.08.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected

